Challenges and Solutions in the Opioid Crisis, Hearing Before the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, Second Session, May 8, 2018 [open pdf - 414KB]
This is the May 8, 2018 hearing on "Challenges and Solutions in the Opioid Crisis," held before the United States House of Representatives Committee on the Judiciary. From the opening statement of Bob Goodlatte: "America is in the middle of an epidemic it has never seen before. The opioid crisis knows no bounds. It is affecting individuals and families in every congressional district. Its consequences, ranging from personal health to the economy, are devastating. The opioid epidemic represents the convergence of the abuses of opioids, heroin, and synthetic drugs like fentanyl. Individuals suffering from addiction often switch between using opioids and heroin, based on a variety of factors including cost and purity. Drug traffickers are further exploiting personal misery by adding deadly fentanyl analogues to the heroin and the illicit opioid supplies to increase their profits. Sadly, unwary and unsuspecting users are suffering deadly results. More frequently, pure fentanyl analogues in the illicit drug supply are resulting in overdose deaths and injuries to first responders. Since these analogues can be deadly in quantities as little as two milligrams, police and other first responders can unknowingly inhale airborne fentanyl or have it come in contact with their skin, causing them to overdose and suffer other severe reactions." Statements, letters, and materials submitted for the record include those of the following: Robert W. Patterson, Timothy Westlake, J. Spencer Morgan III, Kristen Holman, and Josiah Rich.
Serial No. 115-57
U.S. Government Publishing Office: http://www.gpo.gov/